Plasma biomarkers for neurodegenerative disorders: ready for prime time?
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Plasma biomarkers for neurodegenerative disorders: ready for prime time?
Authors
Keywords
-
Journal
CURRENT OPINION IN PSYCHIATRY
Volume 36, Issue 2, Pages 112-118
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2023-01-07
DOI
10.1097/yco.0000000000000851
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The accuracy and robustness of plasma biomarker models for amyloid PET positivity
- (2022) Andréa L. Benedet et al. Alzheimers Research & Therapy
- Plasma biomarkers for Alzheimer’s Disease in relation to neuropathology and cognitive change
- (2022) Denis S. Smirnov et al. ACTA NEUROPATHOLOGICA
- Blood Tests for Alzheimer’s Disease: Increasing Efforts to Expand and Diversify Research Participation Is Critical for Widespread Validation and Acceptance
- (2022) Thomas K. Karikari JOURNAL OF ALZHEIMERS DISEASE
- Performance of plasma phosphorylated tau 181 and 217 in the community
- (2022) Michelle M. Mielke et al. NATURE MEDICINE
- Blood phospho-tau in Alzheimer disease: analysis, interpretation, and clinical utility
- (2022) Thomas K. Karikari et al. Nature Reviews Neurology
- Effect of Race on Prediction of Brain Amyloidosis by Plasma Aβ42/Aβ40, Phosphorylated Tau, and Neurofilament Light
- (2022) Suzanne E. Schindler et al. NEUROLOGY
- An accurate fully automated panel of plasma biomarkers for Alzheimer's disease
- (2022) Sebastian Palmqvist et al. Alzheimers & Dementia
- Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer’s disease
- (2022) João Pedro Ferrari-Souza et al. MOLECULAR PSYCHIATRY
- Differences between blood and cerebrospinal fluid glial fibrillary Acidic protein levels: The effect of sample stability
- (2022) Joel Simrén et al. Alzheimers & Dementia
- Global and local ancestry modulate APOE association with Alzheimer’s neuropathology and cognitive outcomes in an admixed sample
- (2022) Michel Satya Naslavsky et al. MOLECULAR PSYCHIATRY
- Plasma and CSF biomarkers in a memory clinic: Head‐to‐head comparison of phosphorylated tau immunoassays
- (2022) Nicholas J. Ashton et al. Alzheimers & Dementia
- Brain-derived tau: a novel blood-based biomarker for Alzheimer’s disease-type neurodegeneration
- (2022) Fernando Gonzalez-Ortiz et al. BRAIN
- Differential roles of Aβ42/40, p-tau231 and p-tau217 for Alzheimer’s trial selection and disease monitoring
- (2022) Nicholas J. Ashton et al. NATURE MEDICINE
- Serum GFAP and NfL Levels Differentiate Subsequent Progression and Disease Activity in Patients With Progressive Multiple Sclerosis
- (2022) Christian Barro et al. Neurology-Neuroimmunology & Neuroinflammation
- Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer’s disease
- (2021) Pratishtha Chatterjee et al. Translational Psychiatry
- Plasma p-tau231: a new biomarker for incipient Alzheimer’s disease pathology
- (2021) Nicholas J. Ashton et al. ACTA NEUROPATHOLOGICA
- The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers
- (2021) N. J. Ashton et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
- (2021) Henrik Zetterberg et al. Molecular Neurodegeneration
- Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer’s disease
- (2021) Joana B Pereira et al. BRAIN
- Transitioning from cerebrospinal fluid to blood tests to facilitate diagnosis and disease monitoring in Alzheimer's disease
- (2021) D. O. T. Alawode et al. JOURNAL OF INTERNAL MEDICINE
- Use of plasma biomarkers for AT(N) classification of neurodegenerative dementias
- (2021) Daniel Alcolea et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- GFAP as a biomarker in frontotemporal dementia and primary psychiatric disorders: diagnostic and prognostic performance
- (2021) Kasper Katisko et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group
- (2021) Bruno Dubois et al. LANCET NEUROLOGY
- Prediction of future Alzheimer’s disease dementia using plasma phospho-tau combined with other accessible measures
- (2021) Sebastian Palmqvist et al. NATURE MEDICINE
- Developing the ATX(N) classification for use across the Alzheimer disease continuum
- (2021) Harald Hampel et al. Nature Reviews Neurology
- Associations of Fully Automated CSF and Novel Plasma Biomarkers With Alzheimer Disease Neuropathology at Autopsy
- (2021) Michel J. Grothe et al. NEUROLOGY
- A multicentre validation study of the diagnostic value of plasma neurofilament light
- (2021) Nicholas J. Ashton et al. Nature Communications
- Seven day pre-analytical stability of serum and plasma neurofilament light chain
- (2021) Patrick Altmann et al. Scientific Reports
- Head-to-Head Comparison of 8 Plasma Amyloid-β 42/40 Assays in Alzheimer Disease
- (2021) Shorena Janelidze et al. JAMA Neurology
- Associations of amyloid and neurodegeneration plasma biomarkers with comorbidities
- (2021) Jeremy A. Syrjanen et al. Alzheimers & Dementia
- Characterization of pre‐analytical sample handling effects on a panel of Alzheimer's disease–related blood‐based biomarkers: Results from the Standardization of Alzheimer's Blood Biomarkers (SABB) working group
- (2021) Inge M. W. Verberk et al. Alzheimers & Dementia
- Blood-based biomarkers for Alzheimer's disease: towards clinical implementation
- (2021) Charlotte E Teunissen et al. LANCET NEUROLOGY
- Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum
- (2021) Andréa L. Benedet et al. JAMA Neurology
- N-terminal and mid-region tau fragments as fluid biomarkers in neurological diseases
- (2021) Anniina Snellman et al. BRAIN
- Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts
- (2020) Thomas K Karikari et al. LANCET NEUROLOGY
- An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders
- (2020) Nicholas J. Ashton et al. Nature Reviews Neurology
- Plasma p-tau181 accurately predicts Alzheimer’s disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline
- (2020) Juan Lantero Rodriguez et al. ACTA NEUROPATHOLOGICA
- Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders
- (2020) Sebastian Palmqvist et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- NfL as a biomarker for neurodegeneration and survival in Parkinson disease
- (2020) David Bäckström et al. NEUROLOGY
- Serum neurofilament light as a biomarker in progressive multiple sclerosis
- (2020) Raju Kapoor et al. NEUROLOGY
- Serum Glial Fibrillary Acidic Protein (GFAP) Is a Marker of Disease Severity in Frontotemporal Lobar Degeneration
- (2020) Alberto Benussi et al. JOURNAL OF ALZHEIMERS DISEASE
- Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer’s Disease Neuroimaging Initiative
- (2020) Thomas K. Karikari et al. MOLECULAR PSYCHIATRY
- Head‐to‐head comparison of clinical performance of CSF phospho‐tau T181 and T217 biomarkers for Alzheimer's disease diagnosis
- (2020) Thomas K. Karikari et al. Alzheimers & Dementia
- Time course of phosphorylated-tau181 in blood across the Alzheimer’s disease spectrum
- (2020) Alexis Moscoso et al. BRAIN
- Increased plasma neurofilament light chain concentration correlates with severity of post-mortem neurofibrillary tangle pathology and neurodegeneration
- (2019) Nicholas J. Ashton et al. Acta Neuropathologica Communications
- Neurofilament light chain as a biomarker in neurological disorders
- (2019) Lorenzo Gaetani et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease
- (2019) Niklas Mattsson et al. JAMA Neurology
- High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis
- (2019) Suzanne E. Schindler et al. NEUROLOGY
- Plasma and CSF neurofilament light
- (2019) Michelle M. Mielke et al. NEUROLOGY
- Blood NfL
- (2019) Chin-Hsien Lin et al. NEUROLOGY
- High-Throughput Mass Spectrometry Assay for Quantifying β-Amyloid 40 and 42 in Cerebrospinal Fluid
- (2019) Darren M. Weber et al. CLINICAL CHEMISTRY
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- High performance plasma amyloid-β biomarkers for Alzheimer’s disease
- (2018) Akinori Nakamura et al. NATURE
- Serum GFAP as a biomarker for disease severity in multiple sclerosis
- (2018) A. Abdelhak et al. Scientific Reports
- Learnings about the complexity of extracellular tau aid development of a blood-based screen for Alzheimer's disease
- (2018) Zhicheng Chen et al. Alzheimers & Dementia
- Blood-based NfL
- (2017) Oskar Hansson et al. NEUROLOGY
- Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease
- (2017) Niklas Mattsson et al. JAMA Neurology
- Mixed pathology is more likely in black than white decedents with Alzheimer dementia
- (2015) Lisa L. Barnes et al. NEUROLOGY
- Glial fibrillary acidic protein: from intermediate filament assembly and gliosis to neurobiomarker
- (2015) Zhihui Yang et al. TRENDS IN NEUROSCIENCES
- African ancestry protects against Alzheimer's disease-related neuropathology
- (2011) D Schlesinger et al. MOLECULAR PSYCHIATRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now